Marshman Fund Trust II's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Nov 5, 2024
- Accession no.
- 0001213900-24-094563
- Filed
- Nov 5, 2024
- Trade date
- Nov 1-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $139.4M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Marshman Fund Trust IICIK 0001821461 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | SSaleDisposed | −4,000,000 | $30.30 | −$121,200,000 | 6,651,120 | Direct | |
| Nov 5, 2024 | Common Stock | SSaleDisposed | −600,000 | $30.30 | −$18,180,000 | 6,051,120 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.